News & Updates

Show Multimedia Only

Prof Francis Chan: Reflections on tenure as Dean and vision on HK’s future of medical innovation

02 Feb 2024 by

As Professor Francis Chan reflected on his 11-year service as Dean of the Faculty of Medicine, the Chinese University of Hong Kong (CUHK), he shared his vision on the future of healthcare development in Hong Kong and how the city has the potential to become a hub for medical innovation and technology (I&T).

Prof Francis Chan: Reflections on tenure as Dean and vision on HK’s future of medical innovation

02 Feb 2024

Nivolumab-ipilimumab improves PFS in MSI-H/dMMR metastatic CRC

02 Feb 2024 by

In the first-line treatment of patients with microsatellite instability-high or mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (CRC), dual immunotherapy using a combination of nivolumab and ipilimumab delivers a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared with chemotherapy, according to the CheckMate 8HW trial presented at ASCO GI 2024.

Nivolumab-ipilimumab improves PFS in MSI-H/dMMR metastatic CRC

02 Feb 2024

Colchicine beneficial in treatment of myopericarditis

01 Feb 2024

In patients who have had a first attack of pericarditis with evidence of myocardial involvement, treatment with colchicine is safe and helps reduce the risk of recurrence, according to a study.

Colchicine beneficial in treatment of myopericarditis

01 Feb 2024

Certain lupus patients prone to flares after COVID-19 vaccination

01 Feb 2024

Among Asian patients with systemic lupus erythematosus (SLE), those who are younger, male, from ethnic minority backgrounds, and have suboptimal disease control at time of vaccination are at increased risk of flares following mRNA COVID-19 vaccination.

Certain lupus patients prone to flares after COVID-19 vaccination

01 Feb 2024

Oxathridine linked to pseudohallucinations

01 Feb 2024

Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist, results in some serious adverse events (AEs), including orthostatic hypotension and pseudohallucinations in healthy male volunteers, results of a study have shown.

Oxathridine linked to pseudohallucinations

01 Feb 2024

Larsucosterol for hepatitis proves safety in phase IIa trial

01 Feb 2024 by

Treatment with larsucosterol is safe and well tolerated in patients with alcohol-associated hepatitis (AH), as shown in a recent study.

Larsucosterol for hepatitis proves safety in phase IIa trial

01 Feb 2024

Glaucoma surgery linked to incidence of early endophthalmitis

01 Feb 2024

The incidence of early endophthalmitis was higher for both glaucoma and combined cataract/glaucoma surgeries than for cataract surgery alone, reveals a study. The incidence was highest among tube shunts.

Glaucoma surgery linked to incidence of early endophthalmitis

01 Feb 2024

Social robot holds promise in autism screening

01 Feb 2024 by

A social robot named HUMANE holds promise in screening for autism by detecting children's eye gaze during storytelling sessions, researchers from the Chinese University of Hong Kong (CUHK) have reported.

Social robot holds promise in autism screening

01 Feb 2024

Physical activity boosts mental health in young people with neurodevelopmental disorders

01 Feb 2024

In children and adolescents with different types of neurodevelopmental disorders, physical activity interventions exert beneficial effects on mental health, including cognitive function, psychological well-being, internalizing, and externalizing problems, according to the results of a meta-analysis.

Physical activity boosts mental health in young people with neurodevelopmental disorders

01 Feb 2024

Early oral antibiotic switch a good alternative to prolonged IV treatment in gram-negative bacteraemia

31 Jan 2024

In the treatment of uncomplicated gram-negative bacteraemia, switching to oral antibiotics within 4 days appears to be effective, with the all-cause mortality risk comparable to that of continued intravenous (IV) antibiotic treatment, according to a study.

Early oral antibiotic switch a good alternative to prolonged IV treatment in gram-negative bacteraemia

31 Jan 2024

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Prof Francis Chan: Reflections on tenure as Dean and vision on HK’s future of medical innovation

Prof Francis Chan: Reflections on tenure as Dean and vision on HK’s future of medical innovation

Nivolumab-ipilimumab improves PFS in MSI-H/dMMR metastatic CRC

Nivolumab-ipilimumab improves PFS in MSI-H/dMMR metastatic CRC

Colchicine beneficial in treatment of myopericarditis

Colchicine beneficial in treatment of myopericarditis

Certain lupus patients prone to flares after COVID-19 vaccination

Certain lupus patients prone to flares after COVID-19 vaccination

Oxathridine linked to pseudohallucinations

Oxathridine linked to pseudohallucinations

Larsucosterol for hepatitis proves safety in phase IIa trial

Larsucosterol for hepatitis proves safety in phase IIa trial

Glaucoma surgery linked to incidence of early endophthalmitis

Glaucoma surgery linked to incidence of early endophthalmitis

Social robot holds promise in autism screening

Social robot holds promise in autism screening

Physical activity boosts mental health in young people with neurodevelopmental disorders

Physical activity boosts mental health in young people with neurodevelopmental disorders

Early oral antibiotic switch a good alternative to prolonged IV treatment in gram-negative bacteraemia

Early oral antibiotic switch a good alternative to prolonged IV treatment in gram-negative bacteraemia